UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 150

Sortiert nach

Current and Emerging Therapeutic Targets for the Treatment of Cholangiocarcinoma: An Updated Review

International journal of molecular sciences, 2023-12, Vol.25 (1), p.543

2023

Link zum Volltext

Verfügbarkeit prüfen

What Is the Timing and Role of Targeted Therapy in Metastatic Melanoma?

The cancer journal (Sudbury, Mass.), 2024-03, Vol.30 (2), p.84

2024

Link zum Volltext

Verfügbarkeit prüfen

Advances in Liquid Biopsy Technology and Implications for Pancreatic Cancer

International journal of molecular sciences, 2023-02, Vol.24 (4), p.4238

2023

Link zum Volltext

Verfügbarkeit prüfen

Overcoming resistance to programmed cell death protein 1 (PD-1) blockade with allogeneic invariant natural killer T-cells (iNKT)

Oncogene, 2024-03, Vol.43 (10), p.758-762

2024

Link zum Volltext

Verfügbarkeit prüfen

Defining a "Fight" Against Cancer

The Journal of the American Osteopathic Association, 2018-09, Vol.118 (9), p.e84

Hadfield, Matthew J

2018

Link zum Volltext

Verfügbarkeit prüfen

Genomic and Molecular Characteristics of Ovarian Carcinosarcoma

American journal of clinical oncology, 2023-12, Vol.46 (12), p.572

2023

Link zum Volltext

Verfügbarkeit prüfen

Risk Factors for Immunotherapy-related Adverse Events (IrAE) in Patients Treated With Immune Checkpoint Inhibitors

American journal of clinical oncology, 2023-04, Vol.46 (4), p.183

2023

Link zum Volltext

Verfügbarkeit prüfen

A fatal case of Immune thrombocytopenia secondary to the immune checkpoint inhibitor ipilimumab in a patient with BRAF wild type metastatic melanoma

Journal of oncology pharmacy practice, 2020-09, Vol.26 (6), p.1530-1532

2020

Link zum Volltext

Verfügbarkeit prüfen

Siliconoma mimicking a locally invasive fungating breast malignancy

The breast journal, 2020-06, Vol.26 (6), p.1253-1254

2020

Link zum Volltext

Verfügbarkeit prüfen

Bursting the bubble: hereditary spherocytosis masking poor glycemic control

Journal of Osteopathic Medicine (Online), 2021-11, Vol.122 (1), p.65-68

2021

Link zum Volltext

Verfügbarkeit prüfen

Response with pembrolizumab in a patient with EGFR mutated non-small cell lung cancer harbouring insertion mutations in V834L and L858R

Journal of oncology pharmacy practice, 2022-04, Vol.28 (3), p.717-721

2022

Link zum Volltext

Verfügbarkeit prüfen

Pharmacist intervention in colorectal cancer screening initiative

Journal of the American Pharmacists Association, 2020-07, Vol.60 (4), p.e109-e116

2020

Link zum Volltext

Verfügbarkeit prüfen

The evolving posology and administration of immune checkpoint inhibitors: subcutaneous formulations

Trends in cancer, 2024-07, Vol.10 (7), p.579

2024

Link zum Volltext

Verfügbarkeit prüfen

Neurologic complications of melanoma

Cancer, 2020-02, Vol.126 (3), p.477-486

2020

Link zum Volltext

Verfügbarkeit prüfen

Evolving treatments and future therapeutic targets in desmoplastic melanoma

Melanoma management, 2021-09, Vol.8 (3), p.MMT56-MMT56

2021

Link zum Volltext

Verfügbarkeit prüfen

The Ashgate Research Companion to Popular Culture in Early Modern England

1st edition., 2014

Link zum Volltext

Verfügbarkeit prüfen

Harnessing artificial intelligence for prostate cancer management

Cell reports. Medicine, 2024-04, Vol.5 (4), p.101506-101506, Article 101506

2024

Link zum Volltext

Verfügbarkeit prüfen

Poly(ADP-ribose) polymerase inhibitors as cancer therapy

Frontiers in bioscience (Landmark. Print), 2013-06, Vol.18 (4), p.1392-1406

2013

Link zum Volltext

Verfügbarkeit prüfen

High risk human papilloma virus induced oropharyngeal squamous cell carcinoma following immune suppressive treatment of multiple sclerosis: Challenges in screening and early diagnosis

Current problems in cancer. Case reports, 2022-06, Vol.6, p.100154, Article 100154

2022

Link zum Volltext

Verfügbarkeit prüfen

Systematic review of blunt abdominal trauma as a cause of acute appendicitis

Annals of the Royal College of Surgeons of England, 2010-09, Vol.92 (6), p.477

2010

Link zum Volltext

Verfügbarkeit prüfen

Updates on the diagnosis, current and future therapeutic options in Merkel-cell carcinoma

Melanoma research, 2021-10, Vol.31 (5), p.421

2021

Link zum Volltext

Verfügbarkeit prüfen

A retrospective analysis and quality improvement education initiative to increase HPV vaccination rates in an inner city primary care clinic

Journal of clinical oncology, 2021-10, Vol.39 (28_suppl), p.213-213

2021

Link zum Volltext

Verfügbarkeit prüfen

Increased Adhesiveness of Red Blood Cells from Sickle Cell Trait Carriers after Exposure to Daunirubicin Breast Cancer Chemotherapeutic Agent

Blood, 2020-11, Vol.136 (Supplement 1), p.5-6

2020

Link zum Volltext

Verfügbarkeit prüfen

Survival outcomes by site of metastatic disease in patients with ovarian cancer (2278)

Gynecologic oncology, 2023-09, Vol.176, p.S302-S303

2023

Link zum Volltext

Verfügbarkeit prüfen

Stimulator of interferon gene (STING) expression as a biomarker for overall survival in PDL1-negative, TMB-low non-small cell lung cancer (NSCLC) treated with immune checkpoint inhibitors (ICIs)

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.9120-9120

2023

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 150

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(97)
Mit Volltextzugriff
(139)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(63)
Life Sciences & Biomedicine
(51)
Humans
(32)
History
(31)
Arts & Humanities
(21)
Social Sciences
(19)
Cultural Studies
(17)
Early Modern History: C 1450/1500 To C 1700
(16)
Literary Studies: C 1500 To C 1800
(15)
Church History
(12)
Oncology
(11)
British & Irish History
(10)
Covid-19
(10)
Infectious Diseases
(10)
Mutation
(10)
Animals
(9)
Biochemistry & Molecular Biology
(9)
Genomics
(9)
Physical Sciences
(9)
Genomes
(8)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Current and Emerging Therapeutic Targets for the Treatment of Cholangiocarcinoma: An Updated Review

What Is the Timing and Role of Targeted Therapy in Metastatic Melanoma?

Advances in Liquid Biopsy Technology and Implications for Pancreatic Cancer

Overcoming resistance to programmed cell death protein 1 (PD-1) blockade with allogeneic invariant natural killer T-cells (iNKT)

Defining a "Fight" Against Cancer

Genomic and Molecular Characteristics of Ovarian Carcinosarcoma

Risk Factors for Immunotherapy-related Adverse Events (IrAE) in Patients Treated With Immune Checkpoint Inhibitors

A fatal case of Immune thrombocytopenia secondary to the immune checkpoint inhibitor ipilimumab in a patient with BRAF wild type metastatic melanoma

Siliconoma mimicking a locally invasive fungating breast malignancy

Bursting the bubble: hereditary spherocytosis masking poor glycemic control

Response with pembrolizumab in a patient with EGFR mutated non-small cell lung cancer harbouring insertion mutations in V834L and L858R

Pharmacist intervention in colorectal cancer screening initiative

The evolving posology and administration of immune checkpoint inhibitors: subcutaneous formulations

Neurologic complications of melanoma

Evolving treatments and future therapeutic targets in desmoplastic melanoma

The Ashgate Research Companion to Popular Culture in Early Modern England

Harnessing artificial intelligence for prostate cancer management

Poly(ADP-ribose) polymerase inhibitors as cancer therapy

High risk human papilloma virus induced oropharyngeal squamous cell carcinoma following immune suppressive treatment of multiple sclerosis: Challenges in screening and early diagnosis

Systematic review of blunt abdominal trauma as a cause of acute appendicitis

Updates on the diagnosis, current and future therapeutic options in Merkel-cell carcinoma

A retrospective analysis and quality improvement education initiative to increase HPV vaccination rates in an inner city primary care clinic

Increased Adhesiveness of Red Blood Cells from Sickle Cell Trait Carriers after Exposure to Daunirubicin Breast Cancer Chemotherapeutic Agent

Survival outcomes by site of metastatic disease in patients with ovarian cancer (2278)

Stimulator of interferon gene (STING) expression as a biomarker for overall survival in PDL1-negative, TMB-low non-small cell lung cancer (NSCLC) treated with immune checkpoint inhibitors (ICIs)

Suchergebnisse filtern